Ewing’s sarcoma :Optimal length of preoperative chimiotherapy

Communication sur le cancer

Ewing’s sarcoma :Optimal length of preoperative chimiotherapy
association ametist

cancer de l'enfant L'ASSOCIATION
osteosarcome enfant
   lutte contre le cancer Accueil
   associations enfants cancer Pourquoi AMETIST ?
   association ostéosarcome Ses missions
   osteosarcome enfant Unité spécialisée
   association malades ostéosarcome Spécificité de l'Unité
   association de cancereux Ses actions
   osteosarcome enfant Actualités

cancer de l'enfant SOUTIENS
osteosarcome enfant
   association cancer Personnalités
   association cancer Témoignages
   association Témoignages Vidéos
   osteosarcome enfant Sites Internet

cancer de l'enfant ILS EN PARLENT
osteosarcome enfant
   aides diverses pour cancéreux Télévision
   oncologie pédiatrique Radios
   osteosarcome enfant Presse
   aide pour le cancer Médias Internet

association enfant cancer PARTICIPER
osteosarcome enfant
   cancer de l'enfant Devenir Membre
   association enfant cancer Faire un don
   association cancers Faire un lien

sarcome de ewing AMETIST ET VOUS
   sarcome ewing Nous contacter
   sarcome cancer Lettre d'information
   sarcome cancer FaceBook AMETIST

pétition enfants cancéreux

carine curtet
Témoignage Intégral de Carine Curtet
Présidente de l'Association AMETIST

vidéo nicole delepine
Témoignage Intégral du Dr Delépine
Pour le film Cancer Business Mortel

vidéo nicole delepine
vidéo nicole delepine

soutien associaiton cancer

Si vous souhaitez contacter Nicole Delepine
Rendez-vous sur son site :
site de Nicole Delépine

information cancer et mdecine

Ewing’s sarcoma :Optimal length of preoperative chimiotherapy

Delépine G., Cornille H., Alkallaf S , Tabbi A. Zahia L. DELEPINE N.

9 th EFORT congress

2008 may 29-31 Nice

Before chemotherapy the soft tissue extension is hypervascularized and often huge


From november 1985 to january 2006, 150 patients were followed or treated by our team.

Among them 80 fullfilled the inclusion criteria:

localized Ewing’s sarcoma

Previously untreated

Computed medical imaging before and after preop chemotherapy

Local treatment by our team with histologic analysis


Evolution of tumoral volume (%)

Among these 80 patients,

42 patients received a short induction

6 weeks are enough for surgeon !

Standard treatment excluded radiotherapy

• In this protocol early extra tumoral en bloc resection without radiotherapy was the standard local treatment.

• It was performed in all cases without risk of neurological sequellaes.

• 3 patients with contaminated margins received postoperative radiotherapy

All limb tumors were resected

• Some cases of reconstructive procedures used after resection of femoral Ewing

All pelvic tumors were resected

• 16 Y old girl with a huge IIB tumor of iliac wing.

• En bloc resection after 6 weeks chemotherapy.

• Skeletal reconstruction using cement. Excellent oncologic and fonctionnal results with 15 years follow up

Even sacroiliac tumors

17 years remission after en bloc resection and reconstruction with cement


Postoperative chemotherapy alternated :

• 6 IPA (Ifosfamide 6 gr/sqm, Cisplatinum 125 mg/ m², Pirarubicine 35 mg/ m²)

• 3 Cyclophosphamide(150 mg/m² 7d)

+Pirarubicine (35 mg/m² d 8 )

• 12 weeks of Vincristine (2 mg/ m² x 12), Actinomycine D (2 mg/ m² x 6)

Valeur pronostique de la durée de la chimiothérapie préopératoire


• This serie shows the excellent long term prognosis of children with localized Ewing’s sarcoma treated by this protocol, with short (6 weeks) bidrug induction.

• and systematic conservative surgery.

• followed by six drugs postoperative chemotherapy


• This serie confirms the results of Hayes

• on patients treated by surgery : 10/11 operated patients were DFS

Therapy for localized ewing's sarcoma. Hayes J.Clin.oncol. 1989, 7, 2, 208-213.

cancer Consulter le document dans sa version complete tumeur

ostocarcome sarcome ewing

traitement sarcome ewing
Accueil | L'association | Faire un Don | Actualités | Actions | Contacts | Sarcomes | Nicole Delépine | Info cancer | Plan du site | Mentions Légales | Webangelis